BIOREGULATOR / DIRECT CATALOG PRICING
Cardiogen
Cardiogen is a Russian bioregulator trade name associated in the literature with the tetrapeptide Ala-Glu-Asp-Arg (AEDR). PubChem contains an AEDR compound record, but a catalog label is not analytical proof that a vial contains that defined molecule.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Bioregulator
Choose a listed format
- 20 mgRequest current pricingRequest pricing
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Cardiogen is a Russian bioregulator trade name associated in the literature with the tetrapeptide Ala-Glu-Asp-Arg (AEDR). PubChem contains an AEDR compound record, but a catalog label is not analytical proof that a vial contains that defined molecule.
The bioregulator classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Bioregulator
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Cardiogen is a Russian bioregulator trade name associated in the literature with the tetrapeptide Ala-Glu-Asp-Arg (AEDR). PubChem contains an AEDR compound record, but a catalog label is not analytical proof that a vial contains that defined molecule.
- Research covered
- AEDR is discussed in a review of cardiovascular-cell senescence pathways. A separate study tested a material named Cardiogen in organotypic heart-tissue explants from young and aged rats, alongside other trade-named peptides.
- Important limit
- The available evidence is review-level or ex-vivo animal tissue from a narrow research lineage. It does not establish human outcomes, and the exact composition of catalog material cannot be independently inferred from the trade name.
FACTUAL FAQ
Cardiogen catalog questions
What formats are currently listed?
20 mg. Current price and stock state appear above.
What did researchers study?
AEDR is discussed in a review of cardiovascular-cell senescence pathways. A separate study tested a material named Cardiogen in organotypic heart-tissue explants from young and aged rats, alongside other trade-named peptides.
What is the most important evidence limit?
The available evidence is review-level or ex-vivo animal tissue from a narrow research lineage. It does not establish human outcomes, and the exact composition of catalog material cannot be independently inferred from the trade name.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →